(-0.67%) 5 073.50 points
(-0.26%) 38 579 points
(-1.19%) 17 455 points
(0.35%) $83.10
(-2.60%) $1.610
(-0.03%) $2 337.60
(0.34%) $27.44
(0.16%) $917.30
(-0.25%) $0.932
(-0.24%) $10.96
(-0.39%) $0.799
(-0.25%) $92.09
Quarter results today
(bmo 2024-04-25)
Expected move: +/- 4.67%
Live Chart Being Loaded With Signals
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit...
Stats | |
---|---|
Today's Volume | 2.13M |
Average Volume | 3.60M |
Market Cap | 20.79B |
EPS | $0 ( 2024-02-08 ) |
Next earnings date | ( $0.610 ) 2024-05-02 |
Last Dividend | $0.290 ( 2024-02-29 ) |
Next Dividend | $0 ( N/A ) |
P/E | -272.87 |
ATR14 | $0.0180 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Toth Christopher A. | Buy | 119 076 | Common Stock, $1 par value |
2024-03-06 | Stevens Brian | Buy | 14 289 | Common Stock, $1 par value |
2024-03-06 | Sonig Alok | Buy | 83 353 | Common Stock, $1 par value |
2024-03-06 | Rosenbloom David S. | Buy | 53 584 | Common Stock, $1 par value |
2024-03-06 | Rasul Reazur | Buy | 83 353 | Common Stock, $1 par value |
INSIDER POWER |
---|
77.34 |
Last 100 transactions |
Buy: 1 860 689 | Sell: 191 040 |
Volume Correlation
Baxter International Inc Correlation
10 Most Positive Correlations | |
---|---|
LOCL | 0.91 |
PAK | 0.91 |
RSF | 0.905 |
ZME | 0.905 |
GAZ | 0.903 |
UNG | 0.902 |
GDMA | 0.897 |
UNL | 0.892 |
UBP | 0.889 |
RKLY | 0.889 |
10 Most Negative Correlations | |
---|---|
FSNB | -0.946 |
LHC | -0.934 |
PORT | -0.928 |
ALCC | -0.927 |
HWKZ | -0.92 |
NETC | -0.92 |
EVE | -0.919 |
DSAQ | -0.919 |
JMP | -0.918 |
CLBR | -0.918 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Baxter International Inc Correlation - Currency/Commodity
Baxter International Inc Financials
Annual | 2023 |
Revenue: | $14.81B |
Gross Profit: | $4.98B (33.59 %) |
EPS: | $-0.450 |
Q4 | 2023 |
Revenue: | $3.89B |
Gross Profit: | $1.47B (37.89 %) |
EPS: | $0.500 |
Q3 | 2023 |
Revenue: | $3.71B |
Gross Profit: | $1.12B (30.12 %) |
EPS: | $-0.750 |
Q2 | 2023 |
Revenue: | $3.71B |
Gross Profit: | $1.11B (29.97 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Baxter International Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0.290 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0142 | 1982-03-10 |
Last Dividend | $0.290 | 2024-02-29 |
Next Dividend | $0 | N/A |
Payout Date | 2024-04-01 | |
Next Payout Date | N/A | |
# dividends | 150 | -- |
Total Paid Out | $21.30 | -- |
Avg. Dividend % Per Year | 1.37% | -- |
Score | 5.43 | -- |
Div. Sustainability Score | 9.46 | |
Div.Growth Potential Score | 6.41 | |
Div. Directional Score | 7.93 | -- |
Year | Amount | Yield |
---|---|---|
1982 | $0.0568 | 1.35% |
1983 | $0.0692 | 1.21% |
1984 | $0.0808 | 1.41% |
1985 | $0.0908 | 2.80% |
1986 | $0.0988 | 2.59% |
1987 | $0.108 | 2.31% |
1988 | $0.123 | 2.14% |
1989 | $0.138 | 3.17% |
1990 | $0.158 | 2.51% |
1991 | $0.182 | 2.70% |
1992 | $0.217 | 2.25% |
1993 | $0.272 | 3.14% |
1994 | $0.278 | 4.20% |
1995 | $0.301 | 3.94% |
1996 | $1.296 | 11.50% |
1997 | $0.314 | 2.85% |
1998 | $0.315 | 2.32% |
1999 | $0.315 | 1.84% |
2000 | $1.053 | 6.32% |
2001 | $0.316 | 1.30% |
2002 | $0.316 | 1.10% |
2003 | $0.316 | 2.03% |
2004 | $0.316 | 1.93% |
2005 | $0.316 | 1.68% |
2006 | $0.316 | 1.52% |
2007 | $0.392 | 1.55% |
2008 | $0.495 | 1.58% |
2009 | $0.581 | 1.94% |
2010 | $0.642 | 2.03% |
2011 | $0.686 | 2.50% |
2012 | $0.852 | 3.10% |
2013 | $1.042 | 2.84% |
2014 | $1.112 | 2.96% |
2015 | $0.794 | 1.99% |
2016 | $0.505 | 1.36% |
2017 | $0.610 | 1.37% |
2018 | $0.730 | 1.09% |
2019 | $0.850 | 1.30% |
2020 | $0.955 | 1.11% |
2021 | $1.085 | 1.35% |
2022 | $1.150 | 1.32% |
2023 | $1.160 | 2.27% |
2024 | $0.290 | 0.75% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.178 | 1.500 | 6.45 | 9.67 | [0 - 0.5] |
returnOnAssetsTTM | 0.0939 | 1.200 | 6.87 | 8.24 | [0 - 0.3] |
returnOnEquityTTM | 0.380 | 1.500 | 6.89 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.221 | -1.000 | 7.79 | -7.79 | [0 - 1] |
currentRatioTTM | 1.476 | 0.800 | 7.62 | 6.10 | [1 - 3] |
quickRatioTTM | 0.913 | 0.800 | 9.34 | 7.47 | [0.8 - 2.5] |
cashRatioTTM | 0.491 | 1.500 | 8.38 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.508 | -1.500 | 1.533 | -2.30 | [0 - 0.6] |
interestCoverageTTM | 0.261 | 1.000 | -1.014 | -1.014 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.40 | 2.00 | 8.87 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.04 | 2.00 | 8.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.710 | -1.500 | 3.16 | -4.74 | [0 - 2.5] |
grossProfitMarginTTM | 0.338 | 1.000 | 7.71 | 7.71 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.00863 | 1.000 | -1.827 | -1.827 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.120 | 1.000 | -0.444 | -0.444 | [0.2 - 2] |
assetTurnoverTTM | 0.529 | 0.800 | 9.81 | 7.85 | [0.5 - 2] |
Total Score | 9.46 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.81 | 1.000 | 9.31 | 0 | [1 - 100] |
returnOnEquityTTM | 0.380 | 2.50 | 8.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.04 | 2.00 | 9.32 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.83 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.40 | 2.00 | 8.87 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.221 | 1.500 | 7.79 | -7.79 | [0 - 1] |
pegRatioTTM | 0.0190 | 1.500 | -3.21 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.115 | 1.000 | 9.61 | 0 | [0.1 - 0.5] |
Total Score | 6.41 |
Baxter International Inc
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators